A Study to Evaluate the Efficacy and Safety of Zenapax in Combination With CellCept, Cyclosporine, and Corticosteroids in Patients Undergoing Cardiac Transplantation

NCT00048165 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

434

Enrollment

INDUSTRY

Sponsor class

Conditions

Heart Transplantation

Interventions

DRUG: Daclizumab
DRUG: Methylprednisolone
DRUG: Mycophenolate mofetil
DRUG: Placebo
DRUG: cyclosporine

Sponsor

Hoffmann-La Roche